| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787672 | Journal of Thoracic Oncology | 2018 | 24 Pages |
Abstract
Early mortality with the use of adjuvant chemotherapy after complete resection of NSCLC is a clinical concern. The risk is higher in patients older than 70 years, with higher comorbidity scores and a prolonged length of stay postoperatively.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Daniel MD, Pamela S. MD, Saiama N. M.B.B.S., Siddhartha MD, Clifford G. MD, Ramaswamy MD, Varun MD,